Week In Review: Sorrento Announces MAb Inhibits 100% Of SARS-CoV-2 Infection
May 16, 2020 at 16:08 PM EDT
Sorrento Therapeutics, a San Diego-China biotech, reported that its anti-SARS-CoV-2 antibody, STI-1499, completely inhibited SARS-CoV-2 virus infection from interacting with the ACE2 receptor, after four days of incubation.
